Ashish Mandelia, VP, Chief Accounting Officer: Mersana Therapeutics MRSN Sell · Filed 24/10/07

Trade details

Type: Insider sale
Amount: $6,587.56
Shares · price: 3,361 sh · $1.96 a share
Held after: 47,757 sh
Stock: Mersana Therapeutics MRSN
Person: Ashish MandeliaVP, Chief Accounting Officer
Trade date: 24/10/03
Filed: 24/10/07
Days to filing: 4 days

Sold 6.6% of holdings

Share of holding sold: 6.6%

Mersana Therapeutics trades, last 26 weeks

What else happened in Mersana Therapeutics around then

Filed or reported within 30 days of the trade day · 24/09/03~24/11/02

Ashish Mandelia's recent trades

Ashish MandeliaVP, Chief Accounting Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$2,061
3,554 sh
$2,061
Filed 25/01/17
Traded 25/01/16
Ashish MandeliaVP, Chief Accounting Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$1,128
1,791 sh
$1,128
Filed 25/01/16
Traded 25/01/15
Ashish MandeliaVP, Chief Accounting Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$665
1,007 sh
$665
Filed 25/01/15
Traded 25/01/14
Ashish MandeliaVP, Chief Accounting Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$9,710
4,855 sh
$9,710
Filed 24/10/07
Traded 24/10/02
Ashish MandeliaVP, Chief Accounting Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$13.6K
5,025 sh
$13.6K
Filed 24/01/17
Traded 24/01/16

Ashish Mandelia, CAO — sold $6,588 of Mersana Therapeutics MRSN · 6.6% of holdings · 10b5-1 plan | Whalegun